Cocktail and Poster viewing Poster Display session

22P - Therapeutic potential of connective tissue growth factor (CTGF) in triple-negative breast cancer (ID 104)

Presentation Number
22P
Lecture Time
18:25 - 18:25
Speakers
  • H. Kim
Location
Hall Bordeaux, Palais des Congrès, Paris, France
Date
26.02.2019
Time
18:00 - 18:45
Authors
  • H. Kim
  • S. Son

Abstract

Background

Matricellular proteins are a subset of extracellular matrix (ECM) proteins which are dynamically expressed and serve many regulatory roles. Among matricellular proteins, the CCN family, a group of secreted proteins are known to regulate cell adhesion, migration, proliferation, differentiation, apoptosis, survival, senescence, and gene expression. Connective tissue growth factor (CTGF), also known as CCN2, is a member of the CCN family. CTGF is known to have many roles in biological processes such as cell proliferation, migration, adhesion, and angiogenesis.

Methods

To investigate the function of CTGF in triple-negative breast cancer cells (TNBC), we silenced CTGF in TNBC cell lines using short hairpin RNA. Knockdown of CTGF was verified by western blot, qPCR, and immunostaining. The effect of CTGF knockdown on TNBCs was examined by cell proliferation assay, adhesion assay, migration assays, metabolism assays, and cell cycle analysis.

Results

Knockdown of CTGF decreased cell proliferation, adhesion, migration, glucose uptake, ATP production and lactate production. Since CTGF is a secreted protein, we gave recombinant human CTGF (rhCTGF) to the cells and found that rhCTGF induced activation of the Src/FAK/MAPK pathway and led to expression of proteins related to cell cycle progression. Also, when CTGF-specific antibodies were given to the cells, they expressed cytotoxicity by neutralizing the extracellular CTGF and decreasing CTGF-mediated signalling.

Conclusions

We suggest that the secreted CTGF mediates tumor cell progression via modulation of cell proliferation, adhesion, migration and metabolism and could possess a potential for being a therapeutic target.

Legal entity responsible for the study

Hanyang University.

Funding

National Research Foundation of Korea.

Disclosure

All authors have declared no conflicts of interest.

Collapse